| 1 | Tau in Alzheimer Disease and Related Tauopathies | Current Alzheimer Research | 2010 | 991 |
| 2 | Baseline MRI Predictors of Conversion from MCI to Probable AD in the ADNI Cohort | Current Alzheimer Research | 2009 | 511 |
| 3 | Cognitive Reserve in Aging | Current Alzheimer Research | 2011 | 501 |
| 4 | Insulin Resistance and Alzheimers Disease Pathogenesis: Potential Mechanisms and Implications for Treatment | Current Alzheimer Research | 2007 | 461 |
| 5 | Diagnosis of Alzheimers Disease from EEG Signals: Where Are We Standing? | Current Alzheimer Research | 2010 | 446 |
| 6 | Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimers Disease | Current Alzheimer Research | 2012 | 415 |
| 7 | Body Mass Index in Midlife and Risk of Alzheimer Disease and Vascular Dementia | Current Alzheimer Research | 2007 | 400 |
| 8 | Role of the Blood-Brain Barrier in the Pathogenesis of Alzheimers Disease | Current Alzheimer Research | 2007 | 349 |
| 9 | N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer’s Disease, Vascular Dementia and Parkinson’s Disease | Current Alzheimer Research | 2012 | 349 |
| 10 | Targeting Tumor Necrosis Factor Alpha for Alzheimer’s Disease | Current Alzheimer Research | 2017 | 330 |
| 11 | Cholinesterases: Roles in the Brain During Health and Disease | Current Alzheimer Research | 2005 | 328 |
| 12 | Current Advances on Different Kinases Involved in Tau Phosphorylation, and Implications in Alzheimers Disease and Tauopathies | Current Alzheimer Research | 2005 | 304 |
| 13 | Molecular Basis of Familial and Sporadic Alzheimer's Disease | Current Alzheimer Research | 2016 | 303 |
| 14 | Metabolic Dysfunction in Alzheimers Disease and Related Neurodegenerative Disorders | Current Alzheimer Research | 2012 | 297 |
| 15 | Amyloid-Beta Protein Clearance and Degradation (ABCD) Pathways and their Role in Alzheimer’s Disease | Current Alzheimer Research | 2015 | 295 |
| 16 | Oxidative Stress: Apoptosis in Neuronal Injury | Current Alzheimer Research | 2006 | 279 |
| 17 | Tau in Alzheimer's Disease: Mechanisms and Therapeutic Strategies | Current Alzheimer Research | 2018 | 276 |
| 18 | Oxidative Stress Signaling in Alzheimers Disease | Current Alzheimer Research | 2008 | 272 |
| 19 | The Minority Aging Research Study: Ongoing Efforts to Obtain Brain Donation in African Americans without Dementia | Current Alzheimer Research | 2012 | 267 |
| 20 | Astrocytes: Implications for Neuroinflammatory Pathogenesis of Alzheimers Disease | Current Alzheimer Research | 2011 | 264 |
| 21 | Memantine Treatment in Patients with Mild to Moderate Alzheimers Disease Already Receiving a Cholinesterase Inhibitor: A Randomized, Double-Blind, Placebo-Controlled Trial | Current Alzheimer Research | 2008 | 258 |
| 22 | Role of Environmental Contaminants in the Etiology of Alzheimer’s Disease: A Review | Current Alzheimer Research | 2015 | 257 |
| 23 | Long-Term Follow-Up of Patients Immunized with AN1792: Reduced Functional Decline in Antibody Responders | Current Alzheimer Research | 2009 | 252 |
| 24 | FTD and ALS: A Tale of Two Diseases | Current Alzheimer Research | 2011 | 249 |
| 25 | Probiotic Supplementation in Patients with Alzheimer’s Dementia - An Explorative Intervention Study | Current Alzheimer Research | 2018 | 243 |
| 26 | Insulin Resistance and Alzheimers Disease: Molecular Links & Clinical Implications | Current Alzheimer Research | 2008 | 242 |
| 27 | Biomarkers for Alzheimer's Disease Diagnosis | Current Alzheimer Research | 2017 | 242 |
| 28 | The Molecular Basis of Memantine Action in Alzheimers Disease and Other Neurologic Disorders: Low-affinity, Uncompetitive Antagonism | Current Alzheimer Research | 2005 | 241 |
| 29 | Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology | Current Alzheimer Research | 2015 | 241 |
| 30 | Has the Amyloid Cascade Hypothesis for Alzheimers Disease been Proved? | Current Alzheimer Research | 2006 | 235 |
| 31 | A Speech Recognition-based Solution for the Automatic Detection of Mild Cognitive Impairment from Spontaneous Speech | Current Alzheimer Research | 2018 | 230 |
| 32 | Relation of Obesity to Cognitive Function: Importance of Central Obesity and Synergistic Influence of Concomitant Hypertension. The Framingham Heart Study | Current Alzheimer Research | 2007 | 228 |
| 33 | Early Diagnosis of Alzheimers Disease: Is MCI Too Late? | Current Alzheimer Research | 2009 | 224 |
| 34 | Mitochondria as a Therapeutic Target for Aging and Neurodegenerative Diseases | Current Alzheimer Research | 2011 | 212 |
| 35 | Epidemiology and Etiology of Alzheimer’s disease: From Genetic to Non- Genetic Factors | Current Alzheimer Research | 2013 | 202 |
| 36 | Neuroinflammation and Alzheimer's Disease: Implications for Microglial Activation | Current Alzheimer Research | 2017 | 191 |
| 37 | Alzheimers Disease (AD) and Mild Cognitive Impairment (MCI) Patients are Characterized by Increased BDNF Serum Levels | Current Alzheimer Research | 2010 | 187 |
| 38 | Impact of Cytokines and Chemokines on Alzheimer’s Disease Neuropathological Hallmarks | Current Alzheimer Research | 2017 | 187 |
| 39 | Estimating Alzheimer’s Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia | Current Alzheimer Research | 2018 | 187 |
| 40 | TNF-α Inhibition as a Treatment Strategy for Neurodegenerative Disorders: New Drug Candidates and Targets | Current Alzheimer Research | 2007 | 185 |
| 41 | Targeting Phospho-Ser422 by Active Tau Immunotherapy in the THYTau22 Mouse Model: A Suitable Therapeutic Approach | Current Alzheimer Research | 2012 | 185 |
| 42 | Butyrylcholinesterase as a Diagnostic and Therapeutic Target for Alzheimer's Disease | Current Alzheimer Research | 2016 | 183 |
| 43 | Amyloidogenesis of Natively Unfolded Proteins | Current Alzheimer Research | 2008 | 182 |
| 44 | Rosiglitazone Does Not Improve Cognition or Global Function when Used as Adjunctive Therapy to AChE Inhibitors in Mild-to-Moderate Alzheimers Disease: Two Phase 3 Studies | Current Alzheimer Research | 2011 | 182 |
| 45 | Alzheimer’s Disease and Environmental Exposure to Lead: The Epidemiologic Evidence and Potential Role of Epigenetics | Current Alzheimer Research | 2012 | 182 |
| 46 | Pathways by Which Aβ Facilitates Tau Pathology | Current Alzheimer Research | 2006 | 180 |
| 47 | A Common Biological Mechanism in Cancer and Alzheimers Disease? | Current Alzheimer Research | 2009 | 179 |
| 48 | Lipid Alterations in the Earliest Clinically Recognizable Stage of Alzheimers Disease: Implication of the Role of Lipids in the Pathogenesis of Alzheimers Disease | Current Alzheimer Research | 2005 | 176 |
| 49 | Dissecting the Diverse Actions of Pro- and Mature Neurotrophins | Current Alzheimer Research | 2006 | 176 |
| 50 | A Randomized, Double-Blind, Placebo-Controlled Trial of Two Doses of Ginkgo Biloba Extract in Dementia of the Alzheimers Type | Current Alzheimer Research | 2005 | 175 |